TrialBreast cancer (Tokyo, Japan)2026
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial.
Yosuke Aoyama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.